05:40:53 EDT Fri 19 Apr 2024
Enter Symbol
or Name
USA
CA



Cannabis Summary for July 28, 2022

2022-07-28 20:18 ET - Market Summary

This item is part of Stockwatch's value added news feed and is only available to Stockwatch subscribers.

Here is a sample of this item:

by Stockwatch Business Reporter

The S&P/TSX Cannabis Index added 2.19 to 40.24, while the CSE Composite Index lost 1.53 to 280.51. Canadian cannabis grower Tilray Brands Inc. (TLRY) added 49 cents to $4.67 on 4.06 million shares, pleasing investors with its financial results for the fiscal year ended May 31. Considering that the stock spent the prior week falling to $4.18 from $5.08, today's rally likely included a healthy dose of relief that the numbers were not worse.

It is, of course, easier to exceed expectations when they are low to begin with. Analysts were predicting that Tilray would take in revenue of $151.4-million (U.S.) in the fiscal third quarter, which would have been a slight decrease from $152-million (U.S.) in the third quarter. Instead, revenue went the other direction -- if still only slightly -- and came in at $153.3-million (U.S.). Adjusted EBITDA also improved to $11.5-million from $10.1-million, surpassing analysts' predictions of $10.7-million.

The remainder is available to Stockwatch subscribers.
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

© 2024 Canjex Publishing Ltd. All rights reserved.


Reader Comments - Comments are open to paying subscribers of Stockwatch and unmoderated, although libelous remarks, obscene language and impersonations may be deleted. Opinions expressed do not necessarily reflect the views of Stockwatch.
For information regarding Canadian libel law, please view the University of Ottawa's FAQ regarding Defamation and SLAPPs.


Comments for this item are closed